Jonathan Cummings Levy

Jonathan Cummings Levy's AcademicInfluence.com Rankings

Computer Science

#10215

World Rank

#10711

Historical Rank

Data Science

#264

World Rank

#269

Historical Rank

Computational Linguistics

#2582

World Rank

#2607

Historical Rank

Machine Learning

#4680

World Rank

#4732

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Jonathan Cummings Levy's Degrees

PhD Computer Science University of California, Berkeley
Masters Computer Science University of California, Berkeley
Bachelors Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Jonathan Cummings Levy Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jonathan Cummings Levy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 (1998) (5478)
Use and abuse of HOMA modeling. (2004) (4358)
U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease (1995) (1849)
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program (1998) (1848)
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 (1998) (1715)
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study (2002) (1057)
The genetic architecture of type 2 diabetes (2016) (927)
Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. (2003) (770)
Three-year efficacy of complex insulin regimens in type 2 diabetes. (2009) (633)
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. (2007) (618)
Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes (2007) (347)
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998) (331)
A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. (2001) (323)
Beta‐cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10‐year follow‐up of the Belfast Diet Study (1998) (291)
Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. (2011) (284)
Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM (1997) (281)
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes (1999) (271)
Erectile dysfunction in diabetes mellitus. (2009) (223)
PTEN mutations as a cause of constitutive insulin sensitivity and obesity in human beings (2012) (204)
Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. (2000) (191)
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. (2001) (191)
Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. (2003) (184)
Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. (1999) (178)
Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. (2002) (168)
Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to Type 2 diabetes (2004) (137)
The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. (2002) (135)
An increase in insulin sensitivity and basal beta‐cell function in diabetic subjects treated with pioglitazone in a placebo‐controlled randomized study (2004) (129)
Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. (1991) (127)
Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. (1987) (127)
Normalization of Insulin Responses to Glucose by Overnight Infusion of Glucagon-Like Peptide 1 (7–36) Amide in Patients With NIDDM (1996) (126)
Within- and between-subject variation in commonly measured anthropometric and biochemical variables. (1999) (108)
A method for assessing quality of control from glucose profiles (2007) (107)
Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. (2008) (104)
Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial (2018) (102)
Telemedicine Technologies for Diabetes in Pregnancy: A Systematic Review and Meta-Analysis (2016) (100)
Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2 (2013) (95)
Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. (2004) (93)
Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. (1993) (90)
An association analysis of the HLA gene region in latent autoimmune diabetes in adults (2006) (89)
Acceptability and User Satisfaction of a Smartphone-Based, Interactive Blood Glucose Management System in Women With Gestational Diabetes Mellitus (2014) (86)
Type II Diabetes: Clinical Aspects of Molecular Biological Studies (1995) (82)
The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus (Short Communication) (1999) (62)
Clinical Characteristics of Subjects with a Missense Mutation in Glucokinase (1995) (61)
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77 (2007) (58)
The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults (2006) (56)
Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. (2003) (56)
Asian Diabetes in Britain: A Clinical Profile (1986) (55)
Evidence for linkage of stature to chromosome 3p26 in a large U.K. Family data set ascertained for type 2 diabetes. (2002) (55)
Development of a Real-Time Smartphone Solution for the Management of Women With or at High Risk of Gestational Diabetes (2014) (54)
Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects (2001) (49)
Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes (2005) (48)
Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). (2001) (48)
Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. (2003) (44)
Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset. (2004) (43)
A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk (2017) (43)
Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms. (1993) (42)
Hepatic glucose output in humans measured with labeled glucose to reduce negative errors. (1989) (41)
Erectile dysfunction is a strong predictor of poor quality of life in men with Type 2 diabetes mellitus (2014) (40)
Evidence from a large U.K. family collection that genes influencing age of onset of type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24. (2004) (39)
Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients (1999) (35)
Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67) (2005) (34)
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy in NIDDM (1998) (33)
The Gene INPPL 1 , Encoding the Lipid Phosphatase SHIP 2 , Is a Candidate for Type 2 Diabetes In Rat and Man (2002) (32)
Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36:2324–2330 (2014) (32)
Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity. (1990) (31)
Reduced beta cell function in offspring of mothers with young-onset type 2 diabetes (2006) (29)
Distribution of Type II Diabetes in Nuclear Families (1993) (29)
Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate (2006) (29)
Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes (1995) (28)
Analysis of the contribution to type 2 diabetes susceptibility of sequence variation in the gene encoding stearoyl-CoA desaturase, a key regulator of lipid and carbohydrate metabolism (2004) (28)
Normal Proinsulin Responses to Glucose in Mild Type II Subjects With Subnormal Insulin Response (1993) (26)
Simple empirical assessment of Beta-cell function by a constant infusion of glucose test in normal and Type 2 (non-insulin-dependent) diabetic subjects (1991) (26)
Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes‐related traits in UK samples (2005) (26)
Sequence data and association statistics from 12,940 type 2 diabetes cases and controls (2017) (25)
GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes (2006) (25)
The incretin pathway as a new therapeutic target for obesity. (2010) (24)
Segregation analysis of NIDDM in Caucasian families (1994) (23)
Hyperglycaemic Progression in Subjects with Impaired Glucose Tolerance: Association with Decline in Beta Cell Function (1993) (22)
Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes. (2003) (21)
Human calcium/calmodulin-dependent protein kinase II gamma gene (CAMK2G): cloning, genomic structure and detection of variants in subjects with Type II diabetes (2002) (21)
Trial protocol to compare the efficacy of a smartphone-based blood glucose management system with standard clinic care in the gestational diabetic population (2016) (20)
No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians. (2000) (20)
Relative Hyperproinsulinemia of NIDDM Persists Despite the Reduction of Hyperglycemia With Insulin or Sulfonylurea Therapy (1997) (20)
Measurement of Insulin Resistance and Beta-Cell Function: The HOMA and CIGMA Approach (1993) (20)
The impact of screening for Type 2 diabetes in siblings of patients with established diabetes (2003) (19)
Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T). (2017) (19)
Validity of simplified protocols to estimate glomerular filtration rate using iohexol clearance (2007) (19)
Availability of Type II Diabetic Families for Detection of Diabetes Susceptibility Genes (1993) (19)
'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance. (1993) (19)
Ethnic differences in sexual dysfunction among diabetic and nondiabetic males: the Oxford Sexual Dysfunction Study. (2013) (18)
A Genetic Analysis of Type 2 (Non‐insulin‐dependent) Diabetes Mellitus in Punjabi Sikhs and British Caucasoid Patients (1987) (17)
Immunoradiometric assay of insulin, intact proinsulin and 32–33 split proinsulin and radioimmunoassay of insulin in diet-treated Type 2 (non-insulin-dependent) diabetic subjects (1992) (15)
The effect of glibenclamide on insulin secretion at normal glucose concentrations (2014) (14)
No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man (1991) (14)
Skin mini-erosion technique for monitoring metabolites in interstitial fluid: its feasibility demonstrated by OGTT results in diabetic and non-diabetic subjects. (1999) (13)
Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis. (2005) (13)
The association between physical activity and sexual dysfunction in patients with diabetes mellitus of European and South Asian origin: The Oxford Sexual Dysfunction Study (2015) (12)
Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance. (2000) (12)
Linguistic validation of the Sexual Inhibition and Sexual Excitation Scales (SIS/SES) translated into five South Asian languages: Oxford Sexual Dysfunction Study (OSDS) (2013) (12)
Clinical Implications of the NICE 2015 Criteria for Gestational Diabetes Mellitus (2018) (12)
A calculator for HOMA (2004) (12)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Erratum: Butyrylcholinesterase K variant on chromosome 3q is associated with Type II diabetes in white Caucasian subjects (Diabetologia (2001) 44 (2227-2230)) (2002) (9)
The relationship between the insulin resistance syndrome and insulin sensitivity in the first-degree relatives of subjects with non-insulin dependent diabetes mellitus. (1998) (9)
Therapeutic intervention in the GLP‐1 pathway in Type 2 diabetes (2006) (8)
Does type II diabetes arise from a major gene defect producing insulin resistance or beta cell dysfunction (1989) (7)
CIGMA as a tool in the study of NIDDM. (1988) (7)
Impending type 2 diabetes (2009) (6)
Insulin signalling through ultradian oscillations. (2001) (6)
Prevalence and pathophysiology of impaired glucose tolerance in three different high-risk white groups. (1993) (6)
[Evaluation of insulin sensitivity: the HOMA and CIGMA models]. (1998) (5)
Digital blood glucose monitoring could provide new objective assessments of blood glucose control in women with gestational diabetes (2016) (5)
Obesity Associated Insulin Resistance Occurs in Hypopituitary Subjects (1994) (5)
Determinants of within-subject variation of fasting serum leptin concentrations in healthy subjects. (2000) (5)
GDm-Health: a pilot study demonstrating the feasibility of mobile phone assisted treatment advice and medication adjustment for women with gestational diabetes (2014) (5)
Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls (2018) (4)
Ethnicity and neighbourhood deprivation determines the response rate in sexual dysfunction surveys (2015) (4)
[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]. (1993) (4)
Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations (1997) (4)
Primary immunodefi ciency diseases: the J Project (2009) (4)
GLUCOSE-TOLERANCE AND BETA-CELL FUNCTION ASSESSED BY CONTINUOUS INFUSION OF GLUCOSE AND ORAL GLUCOSE-TOLERANCE TEST (1992) (4)
Gut hormones, incretin mimetics and gliptins: new understanding and novel therapies in type 2 diabetes. (2007) (3)
35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
Elevated Plasma Concentrations of β-Cell Tropin (ACTH22–39) in Diet-Treated Type II Diabetic Patients (1992) (3)
Review: UKPDS odyssey — 2001 (2001) (3)
Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM (1996) (2)
Apolipoprotein E genotype is not associated with islet amyloid as assessed by disease severity in type 2 diabetes. (1999) (2)
Real gains but practical limitations to glycaemic control with insulin in type 2 diabetes (2004) (2)
Variation at the insulin VNTR locus but not the CTLA-4 locus is associated with age of onset and need for insulin therapy in latent autoimmune diabetes in adults (LADA) (2001) (2)
Susceptibility for latent autoimmune diabetes in adults (LADA) is determined by variation at the 1DDM2 (insulin-gene) locus in white Caucasian patients from UK repositories (2005) (2)
MATURITY-ONSET DIABETES OF THE YOUNG IS A BETA-CELL DISORDER WITH NORMAL PROINSULIN LEVELS (1993) (2)
Iohexol clearance: Validity of filter paper specimen collection at home (2005) (2)
Plasma 3-OH Butyrate and Triglyceride are Markers of the State of Fat Stores that Regulate Leptin Secretion (1998) (1)
Diabetes in families study: The insulin resistance syndrome segregates into 5 underlying factors in non-diabetic siblings of type 2 diabetic patients (1998) (1)
COMPARISON OF THE ABILITY OF 3 IN-VIVO TESTS TO DISCRIMINATE DIFFERENCES IN BETA-CELL FUNCTION OVER THE RANGE OF GLUCOSE-TOLERANCE (1995) (1)
GDm-Health: telehealth for remote monitoring and treatment of gestational diabetes (2013) (1)
Practical aspects of diabetes in the Asian community (1986) (1)
GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement (2004) (1)
Addition of exenatide to insulin therapy in individuals with type 2 diabetes in UK routine clinical practice (2012) (1)
Siblings of GAD antibody-positive adult-onset diabetic probands are not at increased risk of autoimmune or type 2 diabetes (2003) (1)
A comparison of blood glucose metrics to assess the feasibility of a digital health system for management of women with gestational diabetes: the GDm-Health study (2015) (1)
Perspectives in Diabetes Type I 1 Diabetes : Clinical Aspects of Molecular Biological Studies (2006) (1)
Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS (2005) (1)
Androgen receptor CAG repeat polymorphism is not associated with insulin resistance and diabetes among South Asian males (2017) (1)
Subcutaneous exendin-4 improves 24 hour glucose exposure in type 2 diabetes (2000) (1)
Similar proportional, in spite of differing absolute responses to non-glucose and glucose insulin secretagogues in Type 2 diabetic, LADA and non-diabetic subjects (2007) (1)
Masking of diabetic phenotype on a low-energy diet despite persistence of impaired insulin response. (1991) (1)
ERECTILE DYSFUNCTION AMONG SOUTH ASIAN AND EUROPID MEN WITH AND WITHOUT DIABETES LIVING IN THE UK (2010) (1)
GDm-Health: a pilot study examining acceptability of mobile phone assisted remote blood glucose monitoring for women with gestational diabetes (2014) (1)
Glucagon like peptide-1 similarly amplifies insulin secretion in late-onset type 1 and type 2 diabetes (1999) (0)
In normoglycaemic siblings of type 2 diabetic patients, obesity accounts for decreased insulin sensitivity but not for hypertension. (1998) (0)
GDm-health: development of a real-time smartphone solution for the management of women with gestational diabetes mellitus (GDM) (2015) (0)
Limitations of the microalbumin/creatinine ratio in detecting early microalbuminuria in type 1 diabetes (1999) (0)
PTEN mutations predisposing to monogenic cancer syndrome cause constitutive insulin sensitivity and obesity in humans (2012) (0)
Gestational Diabetes Development of a Real-Time Smartphone Solution for the Management of Women With or at High Risk of (2014) (0)
Increased central adiposity and PAI-1 in siblings of type 2 diabetic subjects with elevated fasting plasma glucose (1999) (0)
Continuous glucose monitoring results from the treating to target in type 2 diabetes (4-T) trial (2008) (0)
Phenotypic effects of inositol 5-phosphatase variants in siblings of UK white Caucasians with type 2 diabetes and non-diabetic controls (2004) (0)
GLUCOSE AND FREE FATTY-ACID TURNOVER AND ASSESSMENT OF INSULIN SENSITIVITY BY A CONSTANT INFUSION OF GLUCOSE TEST (1987) (0)
Diabetes-related sexual dysfunctions (2008) (0)
The BDA Warren Type 2 Diabetes Sibpair Repository: Susceptibility regions identified by genome scan of 439 European families (2000) (0)
Large-scale association studies of candidate genes and their interactions in Type 2 diabetes (2004) (0)
Hyperglycaemic siblings of type 2 diabetic patients have greater central obesity than their normoglycaemic siblings but similar physical activity indices (1998) (0)
RESTING THE BETA-CELLS WITH INSULIN IN NIDDM DOES NOT IMPROVE BETA-CELL FUNCTION NOR PROINSULIN PROCESSING (1995) (0)
SIMPLE ASSESSMENT OF B-CELL FUNCTION IN NORMAL AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS (1989) (0)
Linkage studies of the Type 2 diabetes susceptibility locus on chromosome 1q: Combined analysis of 1200 UK and French affected sibpairs (2002) (0)
Assessment of β-Cell Function / Insulin Sensitivity: HOMA2 Compared with the Hyperglycaemic Clamp, OGTT, Fsivgtt and ITT (1997) (0)
Androgen receptor CAG repeat polymorphism is not associated with insulin resistance and diabetes among South Asian males (2017) (0)
Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter] (2015) (0)
BETA-CELL DYSFUNCTION, INSULIN SENSITIVITY AND SUCCESS OF FAILURE OF DIET TREATMENT IN TYPE-2 DIABETIC-PATIENTS - THE BELFAST PROSPECTIVE-STUDY (1993) (0)
IMPAIRED BETA-CELL FUNCTION BUT NOT SELECTIVE GLUCOSE INSENSITIVITY IN DIET-TREATED TYPE-2 DIABETIC SUBJECTS (1993) (0)
GLP-1 and exendin-4 increase post-prandial leptin in type 2 diabetes (2005) (0)
Insulin Resistance in Human Disease edited by K. B. Huh, S. H. Shinn, T. Kaneko (1994) (0)
Comparison of the metabolic efficacy and bioavailability of intrajejunal insulin solution and insulin dispersion in type 1 diabetes (2000) (0)
IDENTIFYING NUCLEAR FAMILIES IN WOMEN WITH PREVIOUS GESTATIONAL DIABETES - PREVALENCE OF TYPE-2 NON-INSULIN-DEPENDENT DIABETES IN THE PARENTS (1993) (0)
Subcutaneous exendin-4 lowers both post-prandial and fasting plasma glucose in Type 2 diabetes (2000) (0)
GAD65 autoantibody (GADA) titres in latent autoimmune diabetes in adults (LADA) differ from Type 1 diabetes (T1D) and are associated with insulin requirement (2004) (0)
Ethnicity and neighbourhood deprivation determines the response rate in sexual dysfunction surveys (2015) (0)
Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes (1996) (0)
Development of an in silico model to extrapolate whole body glucose - insulin homeostasis by altering tissue specific effects, simulation of SGLT-2 inhibition in type 2 diabetes (2009) (0)
Irish endocrine society (1994) (0)
Difference in insulinotropic effect of elevated plasma saturated, monounsaturated and polyunsaturated fatty acids in healthy man (2001) (0)
Characteristics of patients needing basal insulin to be given twice-daily or a second insulin formulation during the first year of the 4-T Trial (2008) (0)
Susceptibility effects of variation at the IDDM2 (Insulin-gene) locus in latent autoimmune diabetes in adults (LADA). (2003) (0)
Notes on the GENNID Study (1996) (0)
TIMING OF NASAL INSULIN DELIVERY IN TYPE-I DIABETES (1993) (0)
164 THE UPDATED HOMA MODEL: COMPARISON OF PERFORMANCE AGAINST EUGLYCEMIC AND HYPERGLYCEMIC CLAMPS (2005) (0)
MECHANISM OF NON-ESTERIFIED FATTY-ACID SUPPRESSION DURING GLUCOSE INFUSIONS - IMPAIRMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS AND THEIR RELATIVES (1989) (0)
Erratum to: Butyrylcholinesterase K variant on chromosome 3q is associated with Type II diabetes in white Caucasian subjects (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jonathan Cummings Levy?

Jonathan Cummings Levy is affiliated with the following schools:

Jonathan Cummings Levy's Academic­Influence.com Rankings

Jonathan Cummings Levy's Degrees

Similar Degrees You Can Earn

Why Is Jonathan Cummings Levy Influential?

Jonathan Cummings Levy's Published Works

Published Works

What Schools Are Affiliated With Jonathan Cummings Levy?

Jonathan Cummings Levy's AcademicInfluence.com Rankings